Hasbro Leads a Wave of Target Price Upgrades

Analysts lifted their price target on HAS to $109.29, up from $107.07, making it one of the more notable moves in recent activity. The toymaker's consensus average target rose for the second time this week.

Agrochemical giant CTVA saw a split in analyst opinion. One set of estimates pushed the target up to $92.00. Another group nudged it slightly lower to $91.70. The net result was a flat-to-positive tilt from a broadly bullish coverage group — 14 buys vs zero sells.

In materials, MLM — Martin Marietta Materials — took a small hit. The consensus target fell to $671.61 from $676.48. The stock carries one sell rating against 13 buys, suggesting limited downside risk despite the trim.

On the healthcare front, BIIB and REGN both saw targets edged higher. Biogen's average target rose to $234.35. Regeneron's moved to $833.54. Both stocks remain heavily covered by analysts. Biogen has 23 analysts on the stock, all sitting on hold or sell — a cautious tone.

WST — West Pharmaceutical Services — also attracted a target upgrade, pushing consensus to $404.73. Analysts appear broadly positive on the pharma packaging name.